{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T02:29:03Z","timestamp":1793413743418,"version":"4.5.0"},"reference-count":79,"publisher":"EDITORA SCIENTIFIC","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Rev. Bras. Psiquiatr."],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.1590\/1516-4446-2015-1701","type":"journal-article","created":{"date-parts":[[2016,3,12]],"date-time":"2016-03-12T23:26:24Z","timestamp":1457825184000},"page":"65-72","source":"Crossref","is-referenced-by-count":134,"title":["Antidepressive and anxiolytic effects of ayahuasca: a systematic literature review of animal and human studies"],"prefix":"10.47626","volume":"38","author":[{"given":"Rafael G.","family":"dos Santos","sequence":"first","affiliation":[{"name":"Universidade de S\u00e3o Paulo (USP), Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fl\u00e1via L.","family":"Os\u00f3rio","sequence":"additional","affiliation":[{"name":"Universidade de S\u00e3o Paulo (USP), Brazil; Instituto Nacional de Ci\u00eancia e Tecnologia - Medicina Translacional, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Alexandre S.","family":"Crippa","sequence":"additional","affiliation":[{"name":"Universidade de S\u00e3o Paulo (USP), Brazil; Instituto Nacional de Ci\u00eancia e Tecnologia - Medicina Translacional, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaime E. C.","family":"Hallak","sequence":"additional","affiliation":[{"name":"Universidade de S\u00e3o Paulo (USP), Brazil; Instituto Nacional de Ci\u00eancia e Tecnologia - Medicina Translacional, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"27448","reference":[{"key":"ref1","first-page":"9","article-title":"El desarrollo hist\u00f3rico de la identificaci\u00f3n de las malpigi\u00e1ceas empleadas como alucin\u00f3genos","volume":"46","author":"Schultes RE","year":"1986","journal-title":"Am Indig"},{"key":"ref2","article-title":"Plants of the gods: their sacred, healing, and hallucinogenic powers","author":"Schultes RE","year":"1992","journal-title":"Rochester:Healing Arts"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/0378-8741(84)90003-5","article-title":"Monoamine oxidase inhibitors in South American hallucinogenic plants: tryptamine and beta-carboline constituents of ayahuasca","volume":"10","author":"McKenna DJ","year":"1984","journal-title":"J Ethnopharmacol"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s002130000606","article-title":"Subjective effects and tolerability of the South American psychoactive beverage Ayahuasca in healthy volunteers","volume":"154","author":"Riba J","year":"2001","journal-title":"Psychopharmacology (Berl)"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1124\/jpet.103.049882","article-title":"Human pharmacology of ayahuasca: subjective and cardiovascular effects, monoamine metabolite excretion, and pharmacokinetics","volume":"306","author":"Riba J","year":"2003","journal-title":"J Pharmacol Exp Ther"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1002\/dta.1685","article-title":"Metabolism and urinary disposition of N,N-dimethyltryptamine after oral and smoked administration: a comparative study","volume":"7","author":"Riba J","year":"2015","journal-title":"Drug Test Anal"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s00213-006-0358-7","article-title":"Increased frontal and paralimbic activation following ayahuasca, the pan-Amazonian inebriant","volume":"186","author":"Riba J","year":"2006","journal-title":"Psychopharmacology (Berl)"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"2550","DOI":"10.1002\/hbm.21381","article-title":"Seeing with the eyes shut: neural basis of enhanced imagery following Ayahuasca ingestion","volume":"33","author":"de Araujo DB","year":"2012","journal-title":"Hum Brain Mapp"},{"key":"ref9","series-title":"Ayahuasca religions: a comprehensive bibliography and critical essays","author":"Labate BC","year":"2009"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1097\/00005053-199602000-00004","article-title":"Human psychopharmacology of hoasca, a plant hallucinogen used in ritual context in Brazil","volume":"184","author":"Grob CS","year":"1996","journal-title":"J Nerv Ment Dis"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.jep.2007.04.012","article-title":"Effects of ayahuasca on psychometric measures of anxiety, panic-like and hopelessness in Santo Daime members","volume":"112","author":"Santos RG","year":"2007","journal-title":"J Ethnopharmacol"},{"key":"ref12","first-page":"SR15","article-title":"Evidence of health and safety in American members of a religion who use a hallucinogenic sacrament","volume":"14","author":"Halpern JH","year":"2008","journal-title":"Med Sci Monit"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.drugalcdep.2010.03.024","article-title":"Assessment of addiction severity among ritual users of ayahuasca","volume":"111","author":"F\u00e1bregas JM","year":"2010","journal-title":"Drug Alcohol Depend"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1002\/dta.1383","article-title":"Health status of ayahuasca users","volume":"4","author":"Barbosa PC","year":"2012","journal-title":"Drug Test Anal"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"e42421","DOI":"10.1371\/journal.pone.0042421","article-title":"Personality, psychopathology, life attitudes and neuropsychological performance among ritual users of Ayahuasca: a longitudinal study","volume":"7","author":"Bouso JC","year":"2012","journal-title":"PLoS One"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"30","DOI":"10.2174\/15733998113099990003","article-title":"Ayahuasca-assisted therapy for addiction: results from a preliminary observational study in Canada","volume":"6","author":"Thomas G","year":"2013","journal-title":"Curr Drug Abuse Rev"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/978-3-642-40426-9_2","article-title":"The therapeutic potentials of ayahuasca in the treatment of depression","author":"Palhano-Fontes F","year":"2014","journal-title":"The therapeutic use of ayahuasca."},{"key":"ref18","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1590\/1516-4446-2014-1496","article-title":"Antidepressant effects of a single dose of ayahuasca in patients with recurrent depression: a preliminary report","volume":"37","author":"Os\u00f3rio Fde L","year":"2015","journal-title":"Rev Bras Psiquiatr"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1097\/JCP.0b013e31823607f6","article-title":"Autonomic, neuroendocrine and immunological effects of ayahuasca: a comparative study with d-amphetamine","volume":"31","author":"dos Santos RG","year":"2011","journal-title":"J Clin Psychopharmacol"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1007\/s00213-011-2434-x","article-title":"Pharmacology of ayahuasca administered in two repeated doses","volume":"219","author":"dos Santos RG","year":"2012","journal-title":"Psychopharmacology (Berl)"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1080\/02791072.2013.763564","article-title":"Safety and side effects of ayahuasca in humans - - an overview focusing on developmental toxicology","volume":"45","author":"dos Santos RG","year":"2013","journal-title":"J Psychoactive Drugs"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.physbeh.2005.07.006","article-title":"Effects of harmaline on anxiety-related behavior in mice","volume":"86","author":"Hilber P","year":"2005","journal-title":"Physiol Behav"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.bcp.2009.05.011","article-title":"Effects of CYP2D6 status on harmaline metabolism, pharmacokinetics and pharmacodynamics, and a pharmacogenetics-based pharmacokinetic model","volume":"78","author":"Wu C","year":"2009","journal-title":"Biochem Pharmacol"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.euroneuro.2005.08.005","article-title":"Antidepressant-like effect of harmane and other beta-carbolines in the mouse forced swim test","volume":"16","author":"Farzin D","year":"2006","journal-title":"Eur Neuropsychopharmacol"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1016\/j.pnpbp.2009.07.021","article-title":"Acute harmine administration induces antidepressive-like effects and increases BDNF levels in the rat hippocampus","volume":"33","author":"Fortunato JJ","year":"2009","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.brainresbull.2009.09.008","article-title":"Effects of beta-carboline harmine on behavioral and physiological parameters observed in the chronic mild stress model: further evidence of antidepressant properties","volume":"81","author":"Fortunato JJ","year":"2010","journal-title":"Brain Res Bull"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1007\/s00702-010-0451-2","article-title":"Chronic administration of harmine elicits antidepressant-like effects and increases BDNF levels in the rat hippocampus","volume":"117","author":"Fortunato JJ","year":"2010","journal-title":"J Neural Transm"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"325","DOI":"10.4161\/oxim.3.5.13109","article-title":"Harmine and imipramine promote antioxidant activities in prefrontal cortex and hippocampus","volume":"3","author":"R\u00e9us GZ","year":"2010","journal-title":"Oxid Med Cell Longev"},{"key":"ref29","first-page":"987397","article-title":"Administration of harmine and imipramine alters creatine kinase and mitochondrial respiratory chain activities in the rat brain","volume":"2012","author":"R\u00e9us GZ","year":"2012","journal-title":"Depress Res Treat"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1017\/neu.2013.20","article-title":"\u03b2-Carboline harmine reverses the effects induced by stress on behaviour and citrate synthase activity in the rat prefrontal cortex","volume":"25","author":"Abelaira HM","year":"2013","journal-title":"Acta Neuropsychiatr"},{"key":"ref31","first-page":"476","article-title":"Ayahuasca central nervous system effects: behavioral study","volume":"47","author":"Lima LM","year":"2006","journal-title":"\u00c4rztezeitschrift Naturheilverfahren"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1176\/ajp.133.2.203","article-title":"The psychedelic model of schizophrenia: the case of N,N-dimethyltryptamine","volume":"133","author":"Gillin JC","year":"1976","journal-title":"Am J Psychiatry"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1001\/archpsyc.1994.03950020022002","article-title":"Dose-response study of N,N-dimethyltryptamine in humans. II. Subjective effects and preliminary results of a new rating scale","volume":"51","author":"Strassman RJ","year":"1994","journal-title":"Arch Gen Psychiatry"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1080\/02791072.2005.10399801","article-title":"Altered states of consciousness and short-term psychological after-effects induced by the first time ritual use of ayahuasca in an urban context in Brazil","volume":"37","author":"Barbosa PC","year":"2005","journal-title":"J Psychoactive Drugs"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1080\/02791072.2009.10400530","article-title":"A six-month prospective evaluation of personality traits, psychiatric symptoms and quality of life in ayahuasca-na\u00efve subjects","volume":"41","author":"Barbosa PC","year":"2009","journal-title":"J Psychoactive Drugs"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1080\/02791072.2005.10399792","article-title":"Ayahuasca in adolescence: a preliminary psychiatric assessment","volume":"37","author":"Da Silveira DX","year":"2005","journal-title":"J Psychoactive Drugs"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1017\/S1092852900009901","article-title":"Overview of diagnosis and drug treatments of anxiety disorders","volume":"10","author":"Nutt DJ","year":"2005","journal-title":"CNS Spectr"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0376-8716(97)00163-4","article-title":"Investigation of hallucinogenic and related beta-carbolines","volume":"50","author":"Grella B","year":"1998","journal-title":"Drug Alcohol Depend"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0376-8716(99)00148-9","article-title":"Binding of \u03b2-carbolines and related agents at serotonin (5-HT2 and 5-HT1A), dopamine (D2) and benzodiazepine receptors","volume":"60","author":"Glennon RA","year":"2000","journal-title":"Drug Alcohol Depend"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"4421","DOI":"10.1016\/j.bmcl.2003.09.027","article-title":"Binding of \u03b2-carbolines at 5-HT2 serotonin receptors","volume":"13","author":"Grella B","year":"2003","journal-title":"Bioorg Med Chem Lett"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.pharmthera.2003.11.002","article-title":"Hallucinogens","volume":"101","author":"Nichols DE","year":"2004","journal-title":"Pharmacol Ther"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1038\/nrn2884","article-title":"The neurobiology of psychedelic drugs: implications for the treatment of mood disorders","volume":"11","author":"Vollenweider FX","year":"2010","journal-title":"Nat Rev Neurosci"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1177\/2045125314527985","article-title":"Classical hallucinogens as antidepressants? A review of pharmacodynamics and putative clinical roles","volume":"4","author":"Baumeister D","year":"2014","journal-title":"Ther Adv Psychopharmacol"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"103","DOI":"10.2165\/00023210-200923020-00002","article-title":"Current considerations in the treatment of generalized anxiety disorder","volume":"23","author":"Katzman MA","year":"2009","journal-title":"CNS Drugs"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1620\/tjem.191.47","article-title":"The effect of globopentaosylceramide on a depression model, mouse forced swimming","volume":"191","author":"Masuda Y","year":"2000","journal-title":"Tohoku J Exp Med"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0166-4328(02)00311-X","article-title":"Anxiolytic-like effects of 5-HT2 ligands on three mouse models of anxiety","volume":"140","author":"Nic Dhonnchadha BA","year":"2003","journal-title":"Behav Brain Res"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S0166-4328(03)00179-7","article-title":"Evidence for a 5-HT2A receptor mode of action in the anxiolytic-like properties of DOI in mice","volume":"147","author":"Nic Dhonnchadha BA","year":"2003","journal-title":"Behav Brain Res"},{"key":"ref48","article-title":"Serotonin 5-HT2A receptor activation blocks TNF-\u03b1 mediated inflammation in vivo","volume":"8","author":"Nau Jr F","year":"2013","journal-title":"PLoS One"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1080\/02791072.2014.960113","article-title":"Immunological effects of ayahuasca in humans","volume":"46","author":"dos Santos RG","year":"2014","journal-title":"J Psychoactive Drugs"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"e106533","DOI":"10.1371\/journal.pone.0106533","article-title":"Psychedelic N,N-dimethyltryptamine and 5-methoxy-N,N-dimethyltryptamine modulate innate and adaptive inflammatory responses through the sigma-1 receptor of human monocyte-derived dendritic cells","volume":"9","author":"Szabo A","year":"2014","journal-title":"PLoS One"},{"key":"ref51","first-page":"86","article-title":"Psychedelic LSD research","author":"Kurland AA","year":"1971","journal-title":"Psychotropic drugs in the year 2000. Use by Normal Humans."},{"key":"ref52","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1001\/archpsyc.1971.01750070037005","article-title":"LSD revisited. A ten-year follow-up of medical LSD use","volume":"24","author":"McGlothlin WH","year":"1971","journal-title":"Arch Gen Psychiatry"},{"key":"ref53","series-title":"Psychedelic drugs reconsidered","author":"Grispoon L","year":"1981"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1080\/02791072.1994.10472600","article-title":"Psychedelic and entactogenic drugs in the treatment of depression","volume":"26","author":"Riedlinger TJ","year":"1994","journal-title":"J Psychoactive Drugs"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/0893-133X(95)00136-2","article-title":"The psychopharmacology of hallucinogens","volume":"14","author":"Abraham HD","year":"1996","journal-title":"Neuropsychopharmacology"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1080\/02791072.1998.10399711","article-title":"Hallucinogens, serotonin and obsessive-compulsive disorder","volume":"30","author":"Delgado PL","year":"1998","journal-title":"J Psychoactive Drugs"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.1271\/bbb.90095","article-title":"Effects of Psilocybe argentipes on marble-burying behavior in mice","volume":"73","author":"Matsushima Y","year":"2009","journal-title":"Biosci Biotechnol Biochem"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1177\/0269881114531666","article-title":"Repeated lysergic acid diethylamide in an animal model of depression: normalisation of learning behaviour and hippocampal serotonin 5-HT2 signalling","volume":"28","author":"Buchborn T","year":"2014","journal-title":"J Psychopharmacol"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1007\/s00213-006-0457-5","article-title":"Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance","volume":"187","author":"Griffiths RR","year":"2006","journal-title":"Psychopharmacology (Berl)"},{"key":"ref60","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1007\/s00213-011-2358-5","article-title":"Psilocybin occasioned mystical-type experiences: immediate and persisting dose-related effects","volume":"218","author":"Griffiths RR","year":"2011","journal-title":"Psychopharmacology (Berl)"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1177\/0269881110382466","article-title":"Acute, subacute and long-term subjective effects of psilocybin in healthy humans: a pooled analysis of experimental studies","volume":"25","author":"Studerus E","year":"2011","journal-title":"J Psychopharmacol"},{"key":"ref62","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1016\/j.biopsych.2012.04.005","article-title":"Psilocybin biases facial recognition, goal-directed behavior, and mood state toward positive relative to negative emotions through different serotonergic subreceptors","volume":"72","author":"Kometer M","year":"2012","journal-title":"Biol Psychiatry"},{"key":"ref63","series-title":"Psilocybin-induced decrease in amygdala reactivity correlates with enhanced positive mood in healthy volunteers.","first-page":"572","volume":"78","author":"Kraehenmann R","year":"2015"},{"key":"ref64","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/j.biopsych.2014.11.015","article-title":"Acute effects of lysergic acid diethylamide in healthy subjects","volume":"78","author":"Schmid Y","year":"2015","journal-title":"Biol Psychiatry"},{"key":"ref65","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1176\/ajp.144.9.1239b","article-title":"Relief of obsessive-compulsive symptoms by LSD and psilocin","volume":"144","author":"Leonard HL","year":"1987","journal-title":"Am J Psychiatry"},{"key":"ref66","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1097\/00004714-199604000-00011","article-title":"Serotonin, psilocybin, and body dysmorphic disorder: a case report","volume":"16","author":"Hanes KR","year":"1996","journal-title":"J Clin Psychopharmacol"},{"key":"ref67","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1176\/ajp.156.7.1123","article-title":"Hallucinogens and obsessive-compulsive disorder","volume":"156","author":"Perrine DM","year":"1999","journal-title":"Am J Psychiatry"},{"key":"ref68","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1080\/02791072.2014.963754","article-title":"Psilocybin and obsessive compulsive disorder","volume":"46","author":"Wilcox JA","year":"2014","journal-title":"J Psychoactive Drugs"},{"key":"ref69","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.4088\/JCP.v67n1110","article-title":"Safety, tolerability, and efficacy of psilocybin in 9 patients with obsessive-compulsive disorder","volume":"67","author":"Moreno FA","year":"2006","journal-title":"J Clin Psychiatry"},{"key":"ref70","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1001\/archgenpsychiatry.2010.116","article-title":"Pilot study of psilocybin treatment for anxiety in patients with advanced-stage cancer","volume":"68","author":"Grob CS","year":"2011","journal-title":"Arch Gen Psychiatry"},{"key":"ref71","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1097\/NMD.0000000000000113","article-title":"Safety and efficacy of lysergic acid diethylamide-assisted psychotherapy for anxiety associated with life-threatening diseases","volume":"202","author":"Gasser P","year":"2014","journal-title":"J Nerv Ment Dis"},{"key":"ref72","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1177\/0269881114555249","article-title":"LSD-assisted psychotherapy for anxiety associated with a life-threatening disease: a qualitative study of acute and sustained subjective effects","volume":"29","author":"Gasser P","year":"2015","journal-title":"J Psychopharmacol"},{"key":"ref73","doi-asserted-by":"crossref","first-page":"e0118143","DOI":"10.1371\/journal.pone.0118143","article-title":"The psychedelic state induced by ayahuasca modulates the activity and connectivity of the default mode network","volume":"10","author":"Palhano-Fontes F","year":"2015","journal-title":"PLoS One"},{"key":"ref74","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.euroneuro.2015.01.008","article-title":"Long-term use of psychedelic drugs is associated with differences in brain structure and personality in humans","volume":"25","author":"Bouso JC","year":"2015","journal-title":"Eur Neuropsychopharmacol"},{"key":"ref75","doi-asserted-by":"crossref","first-page":"2138","DOI":"10.1073\/pnas.1119598109","article-title":"Neural correlates of the psychedelic state as determined by fMRI studies with psilocybin","volume":"109","author":"Carhart-Harris R","year":"2012","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref76","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1093\/schbul\/sbs117","article-title":"Functional connectivity measures after psilocybin inform a novel hypothesis of early psychosis","volume":"39","author":"Carhart-Harris R","year":"2013","journal-title":"Schizophr Bull"},{"key":"ref77","doi-asserted-by":"crossref","first-page":"925","DOI":"10.2174\/0929867043455594","article-title":"Trends in the development of new antidepressants. Is there a light at the end of the tunnel?","volume":"11","author":"Pacher P","year":"2004","journal-title":"Currt Med Chem"},{"key":"ref78","article-title":"Antidepressant effects of a single dose of ayahuasca in patients with recurrent depression: a SPECT study","author":"Sanches RF","year":"2015","journal-title":"J Clin Psychopharmacol"},{"key":"ref79","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1590\/S0101-60832007000700014","article-title":"Qualidade de vida e espiritualidade","volume":"34","author":"Panzini RG","year":"2007","journal-title":"Rev Psiquiatr Clin"}],"container-title":["Revista Brasileira de Psiquiatria"],"original-title":[],"link":[{"URL":"http:\/\/www.scielo.br\/pdf\/rbp\/v38n1\/1516-4446-rbp-38-01-00065.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,17]],"date-time":"2023-08-17T06:21:30Z","timestamp":1692253290000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S1516-44462016000100065&lng=en&tlng=en"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3]]},"references-count":79,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,3]]}},"alternative-id":["S1516-44462016000100065"],"URL":"https:\/\/doi.org\/10.1590\/1516-4446-2015-1701","relation":{},"ISSN":["1516-4446"],"issn-type":[{"value":"1516-4446","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,3]]}}}